REGHELLIN, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 561
EU - Europa 518
AS - Asia 141
Totale 1.220
Nazione #
US - Stati Uniti d'America 561
GB - Regno Unito 217
CN - Cina 133
SE - Svezia 67
IT - Italia 66
FI - Finlandia 41
IE - Irlanda 37
FR - Francia 35
DE - Germania 31
UA - Ucraina 11
BE - Belgio 8
IN - India 3
IR - Iran 3
RU - Federazione Russa 3
IL - Israele 2
MD - Moldavia 1
NL - Olanda 1
Totale 1.220
Città #
Southend 199
Chandler 113
Jacksonville 106
Woodbridge 54
Ann Arbor 46
Dublin 37
Ashburn 27
Beijing 23
Houston 20
Wilmington 17
Nanjing 16
Shenyang 16
Lawrence 14
Princeton 14
Helsinki 13
New York 12
Verona 10
Jinan 9
Lancaster 9
Brussels 8
Changsha 8
Hebei 8
Nanchang 7
Renton 7
Zhengzhou 7
Ningbo 6
Cambridge 5
Dallas 5
Milan 5
Sindelfingen 5
Dearborn 4
Falls Church 4
Haikou 4
Leawood 4
Redwood City 4
San Mateo 4
Ardabil 3
Boardman 3
Fuzhou 3
Hangzhou 3
Norwalk 3
San Francisco 3
Taiyuan 3
Taizhou 3
Tianjin 3
Augusta 2
Bhavnagar 2
Düsseldorf 2
Guangzhou 2
Rome 2
Washington 2
Amsterdam 1
Apricena 1
Bolzano 1
Büdelsdorf 1
Cagliari 1
Catania 1
Chisinau 1
Clearwater 1
Cupertino 1
Dalian 1
Dongguan 1
Gradisca D'isonzo 1
Licata 1
Monmouth Junction 1
Napoli 1
Nocera Inferiore 1
Novokuznetsk 1
Nürnberg 1
Ravenna 1
Redmond 1
Siano 1
Trieste 1
Vaiano 1
Xiangfen 1
Totale 913
Nome #
Breast cancer with both assessment of Her2/Neu overexpression and gene amplification:clinical impact in selecting patients for drug treatment 134
Perivascular epithelioid cell tumor (PEComa) in the genitourinary tract 119
Lower incidence of triple negative breast cancers within a screening program 97
CARCINOMI DELLA MAMMELLA POSITIVI ALL'IMMUNOESPRESSIONE PER HER-2: VALUTAZIONE CON METODICA FISH DEI CASI CON IMMUNOESPRESSIONE INTRATUMORALE ETEROGENEA 93
Genotypic Intratumoral Heterogeneity in Breast Carcinoma with HER2/neu Amplification Evaluation According to ASCO/CAP Criteria 88
Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature 88
Tasso di inadeguatezza della citologia agoaspirativa con ago sottile (FNAC) di masse superficiali e profonde nell'ambito di un'attività diagnostica integrata cito-radiologica 86
Cancer Size, Histotype, and Cellular Grade May Limit the Success of Fine-Needle Aspiration Cytology for Screen-Detected Breast Carcinoma 83
HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy 82
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 81
Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 cases 74
Molecular pathology of lymphangioleiomyomatosis and other perivascular epithelioid cell tumors 73
PEComas: the past, the present and the future. 68
Is there still a role for fine-needle aspiration cytology in breast cancer screening? Experience of the Verona Mammographic Breast Cancer Screening Program with real-time integrated radiopathologic activity (1999-2004). 67
Totale 1.233
Categoria #
all - tutte 3.280
article - articoli 2.020
book - libri 0
conference - conferenze 1.260
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.560


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201932 0 0 0 0 0 0 0 0 4 6 14 8
2019/2020194 17 3 2 13 15 34 28 17 18 21 10 16
2020/2021146 4 20 3 17 30 15 5 12 7 0 31 2
2021/2022145 7 53 1 30 2 4 1 8 2 3 13 21
2022/2023280 14 37 20 44 37 64 2 18 33 2 3 6
2023/202499 5 9 12 25 20 25 0 1 2 0 0 0
Totale 1.233